VERITTI, Daniele
 Distribuzione geografica
Continente #
NA - Nord America 4.812
EU - Europa 941
AS - Asia 265
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
SA - Sud America 1
Totale 6.029
Nazione #
US - Stati Uniti d'America 4.781
UA - Ucraina 314
IT - Italia 180
CN - Cina 157
DE - Germania 140
IE - Irlanda 86
FI - Finlandia 82
TR - Turchia 68
SE - Svezia 53
GB - Regno Unito 30
CA - Canada 29
VN - Vietnam 20
BE - Belgio 15
IN - India 15
NL - Olanda 13
PL - Polonia 9
TG - Togo 6
AT - Austria 5
RU - Federazione Russa 4
CH - Svizzera 3
AU - Australia 2
EU - Europa 2
JP - Giappone 2
RO - Romania 2
BG - Bulgaria 1
BO - Bolivia 1
ES - Italia 1
FR - Francia 1
GL - Groenlandia 1
HU - Ungheria 1
IL - Israele 1
LU - Lussemburgo 1
MX - Messico 1
PH - Filippine 1
SG - Singapore 1
Totale 6.029
Città #
Woodbridge 666
Fairfield 621
Ann Arbor 468
Houston 430
Chandler 429
Ashburn 320
Seattle 244
Wilmington 240
Cambridge 189
Jacksonville 187
Dearborn 132
Princeton 94
Dublin 86
Beijing 68
Izmir 68
Udine 53
San Diego 39
Ogden 28
Norwalk 26
Falls Church 23
New York 22
Des Moines 21
Dong Ket 20
Boardman 19
Ottawa 18
Brussels 15
Grafing 14
Hefei 10
Nanjing 9
Redmond 9
Warsaw 9
Jinan 8
Wuhan 8
Guangzhou 7
Kunming 7
Rome 7
Toronto 7
Lomé 6
Nanchang 6
Shenzhen 6
Treviso 6
Bologna 5
Chengdu 5
Milan 5
Vienna 5
Andover 4
Chioggia 4
Los Angeles 4
Amsterdam 3
Camponogara 3
Cividale Del Friuli 3
Frankfurt am Main 3
Phoenix 3
Shenyang 3
Turin 3
Venezia 3
Wenzhou 3
Agugliano 2
Baotou 2
Edinburgh 2
Fuzhou 2
Helsinki 2
Indiana 2
Latisana 2
Mestre 2
Montreal 2
Papariano 2
Pignone 2
Pomezia 2
Rio Saliceto 2
Strigno 2
Trieste 2
Washington 2
West Jordan 2
Xian 2
Zurich 2
Aiello Del Friuli 1
Arsiero 1
Budapest 1
Buffalo 1
Changsha 1
Codroipo 1
Deventer 1
Edmonton 1
Eindhoven 1
Foggia 1
Hangzhou 1
Hebei 1
Jiaxing 1
La Paz 1
Leer 1
London 1
Luxembourg 1
Manchester 1
Mel 1
Melbourne 1
Modena 1
Monmouth Junction 1
New Orleans 1
Ningbo 1
Totale 4.766
Nome #
Intravitreal aflibercept for choroidal neovascularization due to age-related macular degeneration unresponsive to ranibizumab therapy 147
Fluocinolone acetonide for the treatment of diabetic macular edema 131
A case of CRB1-negative Coats-like retinitis pigmentosa 130
Optimal Keratoplasty for the Correction of Presbyopia and Hypermetropia 127
Proliferative Diabetic Retinopathy: Treatment Update 125
Triple therapy for corneal neovascularization: A case report 119
Advances in pharmacotherapy for wet age-related macular degeneration 117
Online optical coherence tomography during subthreshold laser irradiation 116
One-year results of aflibercept in vascularized pigment epithelium detachment due to neovascular AMD: A prospective study 116
Neovascular age-related macular degeneration 115
Intravitreal bevacizumab for choroidal neovascularization due to pathologic myopia: long-term outcomes 113
Optical coherence tomography angiography findings in diabetic retinopathy 112
Fundus autofluorescence applications in retinal imaging 111
Bevacizumab and triamcinolone acetonide for choroidal neovascularization due to age-related macular degeneration unresponsive to antivascular endothelial growth factors 108
Effects of VEGF inhibition on retinal morphology, neovascular network size, and visual acuity in patients with vascularized pigment epithelium detachment because of occult choroidal neovascularization. 108
Update on combination therapy in wet age-related macular degeneration 105
Dexamethasone implant with fixed or individualized regimen in the treatment of diabetic macular oedema: Six-month outcomes of the UDBASA study 105
The effect of triamcinolone acetonide, sodium hyaluronate, and chondroitin sulfate on human endothelial cells: An in vitro study 104
Early Effects of Dexamethasone Implant on Macular Morphology and Visual Function in Patients with Diabetic Macular Edema 103
Intravitreal injections: a healthcare failure modes and effects analysis. 102
Dexamethasone implant in diabetic macular edema in real-life situations 102
Drug safety evaluation of intravitreal triamcinolone acetonide 101
Major ocular complications after organ transplantation 101
Low-concentration infracyanine green-assisted internal limiting membrane peeling in idiopathic macular pucker 25-gauge surgery 100
Functional and morphological changes after macular pucker surgery: An optical coherence tomography and microperimetric study 100
Selective laser trabeculoplasty 98
Non-proliferative diabetic retinopathy 97
Author’s response 97
New advances in retina: A report from the International Symposium on Ocular Pharmacology and Therapeutics meeting 96
Ocular complications after hand transplantation 95
Posterior juxtascleral infusion of modified triamcinolone acetonide formulation for refractory diabetic macular edema: One-year follow-up 94
Triple therapy for anti-vascular endothelial growth factor nonresponders in neovascular age-related macular degeneration: Impact of different photodynamic therapy parameters 93
Nonvisible subthreshold micropulse diode laser (810 nm) treatment of central serous chorioretinopathy. A pilot study 91
Different antivascular endothelial growth factor treatments and regimens and their outcomes in neovascular age-related macular degeneration: A literature review 90
Pharmacotherapy for treatment of retinal vein occlusion. 86
null 85
Triamcinolone acetonide for the treatment of diabetic macular oedema 84
Trauma and emergencies 83
Early Response to Intravitreal Dexamethasone Implant Therapy in Diabetic Macular Edema May Predict Visual Outcome 82
Pharmacotherapeutic management of macular edema in diabetic subjects undergoing cataract surgery 81
Intravitreal steroids for the treatment of retinal diseases. 77
Diabetic macular edema 75
One-year outcome of ranibizumab for neovascular age-related macular degeneration: a thorough analysis in a real-world clinical setting. 75
Experience with the Pascal® photocoagulator: An analysis of over 1200 laser procedures with regard to parameter refinement 74
A comparison between a white LED confocal imaging system and a conventional flash fundus camera using chromaticity analysis 74
Early effects of dexamethasone implant on macular morphology and visual function in patients with macular edema secondary to retinal vein occlusion. 73
TWELVE-MONTH OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Fixed Versus As-needed Dosing 73
A Propensity-Score Matching Comparison between 27-Gauge and 25-Gauge Vitrectomy Systems for the Repair of Primary Rhegmatogenous Retinal Detachment 67
Regression of diabetic macular edema after subcutaneous exenatide. 66
Vascular Anomalies of the Fundus Oculi: Diagnosis and Treatment 65
Dexamethasone Implant Produces Better Outcomes than Oral Acetazolamide in Patients with Cystoid Macular Edema Secondary to Retinitis Pigmentosa 65
Steroids in a Combination Strategy 64
null 61
Infection control measures in ophthalmology during the COVID-19 outbreak: A narrative review from an early experience in Italy 58
Intraocular pressure (IOP) after intravitreal dexamethasone implant (Ozurdex) amongst different geographic populations—GEODEX-IOP study 56
Macular pucker 55
Impact on quality of life 47
Dexamethasone implant with fixed or individualized regimen in the treatment of diabetic macular edema: the UDBASA study 43
Ocular Findings in {COVID}-19 Patients: A Review of Direct Manifestations and Indirect Effects on the Eye 41
Subthreshold laser 37
Occhio 33
Edema maculare post occlusione venosa 32
Automated diabetic retinopathy detection with two different retinal imaging devices using artificial intelligence: a comparison study 32
Intravitreal Aflibercept for Choroidal Neovascularization Due to Age-Related Macular Degeneration Unresponsive to Ranibizumab Therapy 31
Combination Therapy for Choroidal Neovascularization Due to Age-Related Macular Degeneration Unresponsive to Anti-VEGF Monotherapy. Intravitreal Bevacizumab and Triamcinolone Acetonide 31
Choriocapillaris and outer choroid blood flow in acute central serous chorioretinopathy: a swept source OCT angiography study 30
Intravitreal Bevacizumab for Choroidal Neovascularization due to Pathological Myopia: Long-term Outcomes 30
The role of steroids in the treatment of diabetic macular edema 29
Anti-VEGF Drugs Dynamics: Relevance for Clinical Practice 29
Present Status of Laser Therapy: Role of Subthreshold Laser 28
Color fundus autofluorescence to determine activity of macular neovascularization in age-related macular degeneration 27
Screening performance of an automated image analysis software for the detection of diabetic retinopathy using a conventional fundus photography or a confocal white LED device: a comparison study 26
Ranibizumab in neovascular age-related macular degeneration: an as-needed treatment regimen with bimonthly evaluation 26
Effects of antithrombotic agents on ophthalmological outcomes, cardiovascular risk, and mortality in hypertensive patients with retinal vein occlusion: An exploratory retrospective study 26
INTRAVITREAL DEXAMETHASONE IMPLANT FOR THE TREATMENT OF DIFFUSE DIABETIC MACULAR EDEMA UNRESPONSIVE TO ANTI-VEGF THERAPY 25
Twelve months outcomes of Intravitreal aflibercept for neovascular age-related macular degeneration. Fixed versus as needed dosing 24
Does the presence of vitreo-macular adhesion influence the outcome of antivascular endothelial growth factor therapy in patients with neovascular agerelated macular degeneration? Systematic review and meta-analysis 24
Chromaticity analysis comparing a white light confocal imaging device versus a flash fundus camera 24
Long-term Effect of Intravitreal Bevacizumab on Chorioretinal Atrophy Progression in Myopic Choroidal Neovascularization 23
One-year efficacy of anti-vascular endothelial growth factor agents in patients with neovascular age-related macular degeneration: a meta-analysis and meta-regression 22
Scleral fixation of a single-piece foldable acrylic IOL through a 1.80 mm corneal incision 20
OCT angiography in chronic central serous chorioretinopathy 20
Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers 20
Diabetic macular edema 17
Pharmacokinetic and Pharmacodynamic Rationale for Extending VEGF Inhibition Increasing Intravitreal Aflibercept Dose 16
Response to:Letter to the editor: Infection control measures in ophthalmology during the COVID-19 outbreak: A narrative review from an early experience in Italy 16
Current role of intravitreal injections in Irvine Gass syndrome-CRIIG study 15
Vitrectomized vs non-vitrectomized eyes in DEX implant treatment for DMO—Is there any difference? the VITDEX study 15
Macular Holes 14
Twelve-month treatment with intravitreal dexamethasone implant for diabetic macular edema 14
One-year outcomes of dexamethasone implant versus oral acetazolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa 13
Managing diabetic macular edema in clinical practice: systematic review and meta-analysis of current strategies and treatment options 13
State-of-the art pharmacotherapy for non-neovascular age-related macular degeneration 11
Long-term outcomes after intravitreal dexamethasone treatment in steroid responders 11
Stem cell therapy in retinal diseases: current evidence 10
Response to: Should we establish a new normality for ophthalmic training in the COVID-19 pandemic? 10
Lens fogging comment on “Infection control measures in ophthalmology during the COVID-19 outbreak: A narrative review from an early experience in Italy” 10
Surgical Management for Diabetic Macular Edema 9
Managing Neovascular Age-Related Macular Degeneration in Clinical Practice: Systematic Review, Meta-Analysis, and Meta-Regression 9
Response to: New norms in ophthalmic surgery during the COVID-19 pandemic: A narrative review from a Malaysia tertiary eye care center 8
Totale 6.239
Categoria #
all - tutte 21.544
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.544


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019472 0 0 0 0 0 0 0 0 0 0 292 180
2019/20201.711 96 70 69 254 131 259 176 185 139 127 34 171
2020/2021926 43 110 56 121 45 92 38 98 124 36 100 63
2021/2022655 31 41 21 18 25 39 54 34 18 119 134 121
2022/2023925 120 64 12 140 91 234 0 70 119 9 32 34
2023/2024284 66 22 6 8 40 35 13 28 45 21 0 0
Totale 6.283